Medicine and Dentistry
Visual Acuity
97%
Laser Coagulation
94%
Diabetic Macular Edema
74%
Diseases
72%
Optical Coherence Tomography
72%
Randomized Clinical Trial
65%
Ranibizumab
59%
Diabetic Retinopathy
52%
Retinopathy
50%
Multimodal Imaging
46%
Maculopathy
44%
Proliferative Diabetic Retinopathy
40%
Visual Impairment
39%
Fluorescein Angiography
35%
Choroidal Neovascularization
34%
Aflibercept
33%
Spectral Domain Optical Coherence Tomography
32%
Optic Nerve
32%
Sickle Cell Retinopathy
31%
Retinal Pigment Epithelium
31%
Vasculotropin
30%
Retina Macula Cystoid Edema
28%
Optical Coherence Tomography Angiography
28%
Autofluorescence
28%
Choroid
27%
Fluorescein
26%
Vitreous
24%
Vitreous Hemorrhage
24%
Retinal Detachment
23%
Multiple Evanescent White Dot Syndrome
23%
Choroiditis
22%
Photoreceptor
21%
Vitrectomy
20%
Capillary
19%
Bevacizumab
19%
Low Level Laser Therapy
19%
Sickle-Cell Disease
17%
Indocyanine Green Angiography
17%
Central Serous Retinopathy
17%
Angiography
17%
Visual Pigment
16%
Acute Posterior Multifocal Placoid Pigment Epitheliopathy
16%
Serpiginous Choroiditis
16%
Subretinal Fluid
15%
Diabetes Control and Complications Trial
15%
Diabetes Mellitus
15%
Chorioretinitis
14%
Insulin Dependent Diabetes Mellitus
14%
Neoplasm
14%
Inflammatory Disorder
14%
Keyphrases
Visual Acuity
100%
Diabetic Macular Edema
91%
Randomized Clinical Trial
73%
Ranibizumab
66%
Aflibercept
48%
Proliferative Diabetic Retinopathy
47%
Multimodal Imaging
43%
Panretinal Photocoagulation
41%
Optical Coherence Tomography
39%
Retina
39%
Fluorescein Angiography
37%
Diabetic Retinopathy
36%
Photocoagulation
36%
Cystoid Macular Edema
34%
Bevacizumab
31%
Spectral Domain Optical Coherence Tomography (SD-OCT)
31%
Myopic Choroidal Neovascularization (mCNV)
31%
Retinal pigment Epithelium
30%
Intravitreous
29%
Neovascularization
29%
Macula
27%
Macular
25%
Optical Coherence Tomography Angiography (OCT-A)
24%
Proliferative Sickle Cell Retinopathy
24%
Multiple Evanescent White Dot Syndrome (MEWDS)
23%
Vitreous Hemorrhage
22%
Laser Therapy
22%
Optic Nerve
22%
Choroidal
22%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
21%
Vitrectomy
21%
Anti-vascular Endothelial Growth Factor Therapy
21%
Retinopathy
20%
Vision Loss
19%
Sickle Cell Disease
19%
Central Serous Chorioretinopathy
19%
Retinal Vein Occlusion
19%
Fundus Autofluorescence
19%
Photoreceptor
18%
Subretinal Fluid
18%
Cytomegalovirus Retinitis
18%
Confidence Interval
17%
Indocyanine Green Angiography
17%
Central Subfield Thickness
17%
Serpiginous Choroiditis
17%
Type 1 Diabetes Mellitus (T1DM)
16%
Diabetes Complications
16%
Occlusion
16%
Acute Posterior multifocal Placoid pigment Epitheliopathy
16%
Multifocal Choroiditis
15%